Clinical trial
OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients…
NCT00041535 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00041535 |
|---|---|
| Title | OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease |
| Official title | A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gaucher Disease |
| Intervention type | Drug |
| Interventions | OGT 918 |
| Enrollment | 30 |
| Start date | Jul 5, 2002 |
| Completion | Mar 21, 2007 |
| First posted | Jul 10, 2002 |
| Last update posted | Jul 2, 2017 |
| Countries | United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: